Chair: Ofra Benny, The Hebrew University of Jerusalem
09:00- 09:15
Ayelet Ofarim Chemical Abstracts Service, Arad Ophir Ltd., Ramat Hasharon, Israel Controlled-release packaging– A case study in SciFinder discovery platform
09:15- 09:30
Osnat Bohana-Kashtan1, Ira Gotliv1, Oded Pinkas1, Haim Tsubery1, Neta Chaim1, Noa Avni1, Hanna Eruhimovich1, Michal Wolk1, Tal Yoetz1, Marcelle Machluf1,2 1R&D, NanoGhost, Netanya, Israel, Israel 2Biotechnology and Food Engineering, Tehnion – Israel Institute of Technology, Haifa, Israel NanoGhost – Harnessing the homing nature of stem cells in a drug targeting platform
09:30- 09:45
Helen Domeshek Drug Substance Development, Recipharm, Yavne, Israel From drug candidate to proof of concept
09:45- 10:00
Mor Goldfeder ., PEEL Therapeutics, Nesher, Israel TBA
10:00- 10:30
Coffee Break
Auditorium Foyer
10:30 – 12:35
ICRS – Session 21: Clinical oncology & cancer targeted delivery
Auditorium
Chair: Dan Peer, Tel Aviv University
10:30 - 10:55
Dan Peer Shmunis School of Biomedicine and Cancer Research, Tel Aviv University, Tel Aviv, Israel RNA therapeutics: From gene silencing to gene editing
10:55- 11:20
Ronit Satchi-Fainaro Tel Aviv University, Tel Aviv, Israel Dendritic cells-targeted nano-vaccines sensitize melanoma to immune checkpoint modulators
11:20- 11:45
Alex Tendler, Alex Tendler, Lana Volokh, Kasuto Harel Bio-Tech, Exoprother Medical, Yokneam, Haifa, Israel P53 containing natural nanovesicles of xenogenic origin as highly effective oncology therapy demonstrated in syngeneic murine model.
11:45 - 12:10
Ofra Benny Faculty of Medicine, School of Pharmacy, The Hebrew University for Jerusalem, Jerusalem, Israel Biomechanical targeting as a novel approach for drug delivery in cancer
12:10- 12:35
Yosi Shamay Biomedical Engineering, Technion – Israel Institute of Technology, Haifa, Israel Nanoinformatics for personalized cancer nanomedicine: From literature data mining to optimized molecular structures